Bruno Baptista graduated in Biotechnology in 2016 at the University of Beira Interior (UBI, Portugal) with a classification of 15 values. In 2018, he completed his MSc in Biomedical Sciences (UBI), where he conducted research at the Health Sciences Research Center (CICS-UBI), obtaining a classification of 18 values, and his dissertation "Potencial terapêutico de miR-9 e miR-29 na doença de Alzheimer", with a classification of 19 values. Bruno investigated the mechanism of action and the function of miR-9 and miR-29 in the regulation of the expression of proteins involved in the mechanisms of Alzheimer's Disease. He acquired knowledge in nucleic acid and protein isolation/extraction, PCR and RT-qPCR, cDNA synthesis, in vitro transcription, nanoparticle formulation, eukaryotic cell transfection, protein quantification, agarose gel electrophoresis and SDS-PAGE, western Blot, immunocytochemistry and fluorescence microscopy (Confocal). After completing his MSc, given his interest in research and to deepen scientific knowledge, he continued his research work as a volunteer for about one year. Between 2019 and 2022, Bruno obtained various research grants (POCI-01-0145-FEDER-029496; BID/ICI-FC/CICS/Santander Universidades-UBI/2021; CENTRO-01-0145-FEDER-072541; EU Project 101047214) in different fields, which gave him hard-skills regarding the purification and stabilization of microRNAs precursors associated to Alzheimer's disease, the development and delivery of nanoparticles for lung cancer treatment, diagnosis and assessment of the immune response to SARS-CoV-2 and establishment of specific mRNA bioproduction and purification process in yeast for the development of mRNA-based drugs and vaccines for diseases. These opportunities also allowed the acquisition of more scientific and laboratory knowledge, from sample preparation for reading in Scanning Electron Microscopy (SEM), measurements of size and surface charge (DLS and ELS), circular dichroism, cell viability assays (MTT and MTS), Live imaging and Fluorescence spectroscopy. This also enabled him and demonstrated his great versatility and multidisciplinary, in addition to his great ability to work in groups. Currently, Bruno has a research grant (2023.01986.BD), which aims to develop a potential therapeutic strategy toward LC, by exploiting the use of p53-mRNA delivery by an innovative hybrid system. Given his academic career and scholarship opportunities, Bruno managed to publish 3 review articles, one of which was selected to be the cover of Pharmaceutics, Volume 13, Issue 12, and has been selected for Best Paper Award for Topical Collection "Women in Pharmaceutics". In 2023, Bruno also published an original in line with the work developed in responsive pH-copolymers, in partnership with the University of Coimbra. In order to expand his scientific and personal knowledge, Bruno also participated in the organization of the "IV International Congress in Health Sciences Research towards innovation and entrepreneurship: Challenges from Research to Clinics". He also participated as an author in 3 oral presentations, being the most important at the ICBBE 2021 and as author and co-author in 7 posters. Bruno also participated as an assistant in several symposiums, workshops and congresses. In order to improve his personal and professional culture, Bruno also obtained the trainer certificate (CCP) by the IEFP, which helped him to acquire some important skills to work as a monitor in the practical classes in various courses. In addition, Bruno co-supervised a MSc students in pharmaceutical sciences and biotechnology and helps in the orientation of students in different scientific areas. Throughout his career he received 4 awards that show his commitment, dedication and willpower in his functions and work.